These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36482288)

  • 21. Lymphopenia predicts reduced survival in canine hepatocellular carcinoma.
    Suarez-Rodriguez JI; Liu CC; Dehghanpir S; Johnston AN
    J Vet Sci; 2023 May; 24(3):e36. PubMed ID: 37271504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
    Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.
    Bai B; Lin Y; Hu J; Wang H; Li L; Zhao S; Zhang J; Meng W; Yue P; Bai Z; Li X
    Oncol Rep; 2019 Mar; 41(3):1539-1548. PubMed ID: 30747220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
    Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
    Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
    Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
    Zhang G; Liu T; Wang Z
    J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
    Gao J; Jia WD
    Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
    Jiang Z; Shen L; Wang S; Wu S; Hu Y; Guo J; Fu L
    Cancer Med; 2019 Dec; 8(17):7278-7287. PubMed ID: 31595711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.
    Zhao J; Chen J; Lin H; Jin R; Liu J; Liu X; Meng N; Cai X
    Pathol Oncol Res; 2016 Jul; 22(3):453-9. PubMed ID: 26589513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.